Research and Reports in Urology最新文献

筛选
英文 中文
Does Size Matter? A Retrospective Study Analysing the Size of PI-RADS 4 Lesions and Its Associated Prostate Cancer Positivity with Transperineal Prostate Biopsy. 大小重要吗?一项通过经会阴前列腺活检分析 PI-RADS 4 病变大小及其相关前列腺癌阳性率的回顾性研究。
IF 2
Research and Reports in Urology Pub Date : 2025-02-25 eCollection Date: 2025-01-01 DOI: 10.2147/RRU.S499930
Ali Hooshyari, David Scholtz, Keu Maoate, Samuel Robertson, Lodewikus Petrus Vermeulen, Luiz Gustavo Modelli De Andrade, Paulo Roberto Kawano, Peter Gilling, Mark Fraundorfer, Flavio Vasconcelos Ordones
{"title":"Does Size Matter? A Retrospective Study Analysing the Size of PI-RADS 4 Lesions and Its Associated Prostate Cancer Positivity with Transperineal Prostate Biopsy.","authors":"Ali Hooshyari, David Scholtz, Keu Maoate, Samuel Robertson, Lodewikus Petrus Vermeulen, Luiz Gustavo Modelli De Andrade, Paulo Roberto Kawano, Peter Gilling, Mark Fraundorfer, Flavio Vasconcelos Ordones","doi":"10.2147/RRU.S499930","DOIUrl":"https://doi.org/10.2147/RRU.S499930","url":null,"abstract":"<p><strong>Introduction: </strong>Magnetic resonance imaging (MRI) is an essential tool in Prostate Cancer (PCa) diagnosis. PI-RADS v2.1 score correlates with clinically significant prostate cancer (CSPCa) and according to the most recent guidelines, prevalence of CSPCa with PI-RADS 4 is 33-41%, while PI-RADS 5 is 62-79%. These groups are separated only by a size of 15 mm yet the difference in risk is significant. This study aims to find a size threshold associated with CSPCa within the PI-RADS 4 group, which may be used in combination with other prostatic parameters, such as PSA density in order to help with risk stratification and patient counselling in the pre-biopsy setting. This may also aid with surveillance of smaller PI-RADS 4 lesions in the setting of a negative biopsy and avoid unnecessary repeat biopsies unless triggered by a size threshold.</p><p><strong>Methods: </strong>A retrospective study was performed with data from 407 patients undergoing transperineal prostate biopsy (TPPB) between April 2022 and November 2023. A subgroup of patients with PI-RADS 4 was included for analysis. A ROC-AUC was obtained.</p><p><strong>Results: </strong>Median age was 67 (interquartile range: 61-71) and PSA density 0.20 (interquartile range 0.13-0.28). PI-RADS score correlated with CSPCa: for PI-RADS 1 and 2, the frequency of CSPCa was 10%; for PI-RADS 3, it was 20%; for PI-RADS 4, it was 60%; and for PI-RADS 5, it was 80%, Pearson correlation = 0.51, p < 0.001. The Receiver Operating Characteristic Area Under the Curve (ROC-AUC) was determined to be 0.664 [0.579-0.7499]. The optimal cut-off point was 8.5 mm. Patients with lesions larger than 8.5 mm had 2.31 times higher risk CSPCa.</p><p><strong>Conclusion: </strong>PI-RADS 4 size does matter and is a useful predictor of CSPCa. In our study, a cut-off of 8.5 mm was identified. The combination of PI-RADS 4 with PSA density provides a specificity higher than 80% for CSPCa detection.</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"17 ","pages":"49-57"},"PeriodicalIF":2.0,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11871869/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143543149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genitofemoral Neuromodulation as a Novel Pain Management Solution for Patients with Chronic Testicular Pain: A Proof-of-Concept Study.
IF 2
Research and Reports in Urology Pub Date : 2025-02-19 eCollection Date: 2025-01-01 DOI: 10.2147/RRU.S507805
Tran Ngoc An Huynh, Jeffrey Jiang, Paul Manohar
{"title":"Genitofemoral Neuromodulation as a Novel Pain Management Solution for Patients with Chronic Testicular Pain: A Proof-of-Concept Study.","authors":"Tran Ngoc An Huynh, Jeffrey Jiang, Paul Manohar","doi":"10.2147/RRU.S507805","DOIUrl":"10.2147/RRU.S507805","url":null,"abstract":"<p><strong>Introduction: </strong>Severe chronic testicular pain that has failed medical therapy and physiotherapy poses a treatment dilemma. This study presents a proof of concept for the use of genitofemoral neuromodulation (GFM) as a potential pain management solution for patients with persistent testicular pain unresponsive to conservative and surgical management.</p><p><strong>Methods: </strong>Patients with chronic testicular pain refractory to conventional treatments were selected for GFM. A total of three patients were included in this proof-of-concept study. Demographic information, prior medical and surgical interventions, and pre- and post-operative pain scores using the Numerical Rating Pain Scale were collected. All patients must have had temporary relief from pain with a spermatic cord block.</p><p><strong>Results: </strong>Patient 1 (75 years old) had a history of opioid medication use, physiotherapy, radiofrequency ablation, and nerve block. His pain score reduced from 10/10 to 4/10 six months post-operatively. Patient 2 (59 years old) had a history of opioid, nortriptyline, baclofen medication use, and physiotherapy. His pain score reduced from 9/10 to 2/10 six months post-operatively. Patient 3 (36 years old) had a history of opioid medication use and physiotherapy, and bilateral orchidectomy for pain relief. His pain score reduced from 8/10 to 6/10 six months post-operatively.</p><p><strong>Conclusion: </strong>This study suggests that GFM is effective in reduce pain scores and could be a viable option for patients with chronic testicular pain refractory to traditional interventions. Further research is essential to establish the long-term efficacy and safety of GFM in this cohort.</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"17 ","pages":"43-47"},"PeriodicalIF":2.0,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11847443/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143484000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical Management of Anterior Urethral Stricture: A 23-year Single-Center Study.
IF 2
Research and Reports in Urology Pub Date : 2025-02-19 eCollection Date: 2025-01-01 DOI: 10.2147/RRU.S507169
Yilong Guo, Ning Ma, Jiaxiong Zhang, Sen Chen, Pingping Liu, Zhe Yang, Yangqun Li
{"title":"Surgical Management of Anterior Urethral Stricture: A 23-year Single-Center Study.","authors":"Yilong Guo, Ning Ma, Jiaxiong Zhang, Sen Chen, Pingping Liu, Zhe Yang, Yangqun Li","doi":"10.2147/RRU.S507169","DOIUrl":"10.2147/RRU.S507169","url":null,"abstract":"<p><strong>Purpose: </strong>Anterior urethral stricture is a common clinical condition in urology with significant socioeconomic impacts and is associated with high recurrence rates of and postoperative complications. However, the long-term outcome of surgical management of urethra stricture and the associated risk factors of stricture recurrence remain limited. We conducted a 23-year single-center retrospective study to evaluate the long-term surgical outcomes of anterior urethral strictures with different clinical characteristics and to study factors that contribute to stricture recurrence.</p><p><strong>Methods: </strong>A retrospective study was conducted on 145 male patients diagnosed with anterior urethral stricture, who underwent meatotomy, anastomotic urethroplasty (AU), penile skin flap urethroplasty (PFU), single-stage buccal mucosa grafting (SSU), or multistage buccal mucosa grafting (MSU) between April 2000 and August 2023. We defined 100 months as the cut-off time point to distinguish short-term and long-term follow-up. Early surgical complications were scored using the Clavien-Dindo classification at 3 months. Patient-Reported Outcome Measure (PROM) was applied to evaluate surgical success. Risk factors for wound complications were evaluated using univariable and multivariable analysis.</p><p><strong>Results: </strong>The overall mean stricture length was 2.3 ± 1.8 cm (a range of 0.3-7.0). Stricture locations were at the meatus, fossa navicularis, penile, bulbar, and multifocal in 15, 36, 79, 9, and 6. The short-term and long-term success rate for meatotomy, AU, PFU, SSU, and MSU were 70.0%/80%, 70.4%/62.5%, 77.8%/69.2%, 100%/75%, and 81.8%/66.7%, respectively. The early complications classified as Clavien grades I, II, III, IV, and V were 39, 5, 5, 0, and 0. The late complication rate in the short-term and long-term groups were 20.3% and 30.3% (p > 0.05). The satisfaction survey showed that 74.5% (108 of 145) patients were satisfied or very satisfied with the surgical result. There was no statistically significant difference in stricture-free survival among the five surgical groups (Log rank test: χ² = 3.83, p > 0.05). The binary univariate logistic regression analysis showed that stricture symptom duration (p < 0.05) and previous urethroplasty (p < 0.05) were independent predictors of surgery failure.</p><p><strong>Conclusion: </strong>This long-term retrospective study on male anterior urethral stricture disease demonstrates that surgical management is an effective and functional treatment. However, the success rate of urethroplasty shows a declining trend with longer follow-up. Stricture symptom duration and previous urethroplasty carry a high risk of surgical failure.</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"17 ","pages":"31-42"},"PeriodicalIF":2.0,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11847449/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143484001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three-Dimensional Virtual Model for Robot-Assisted Partial Nephrectomy (RAPN): Development of Study Protocol for Evaluation of the Learning Curve to Optimize the Precision and Accuracy of the 3D Imaging.
IF 2
Research and Reports in Urology Pub Date : 2025-02-06 eCollection Date: 2025-01-01 DOI: 10.2147/RRU.S503524
Paolo Traverso, Guglielmo Mantica, Veronica Giasotto, Carlo Terrone
{"title":"Three-Dimensional Virtual Model for Robot-Assisted Partial Nephrectomy (RAPN): Development of Study Protocol for Evaluation of the Learning Curve to Optimize the Precision and Accuracy of the 3D Imaging.","authors":"Paolo Traverso, Guglielmo Mantica, Veronica Giasotto, Carlo Terrone","doi":"10.2147/RRU.S503524","DOIUrl":"10.2147/RRU.S503524","url":null,"abstract":"<p><p>3D models have been introduced as tools to improve surgeon's precision during Robotic-Assisted Partial Nephrectomy (RAPN). They showed to provide accurate anatomical details, improve operative time and patient safety by reducing complications. Over the last years, several useful models have been developed and proposed. However, literature is still scant regarding if and how the experience of the operator, and the learning curve, may impact the accuracy and precision of the model. In this light, the aim of the study is to evaluate the accuracy, the interpersonal variability of the precision and the learning curve for the segmentation of RAPN 3D preoperative models starting from CT images. This study will identify the influence of operator experience and learning curves on the accuracy of 3D preoperative models in RAPN, optimizing workflows for broader clinical adoption.</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"17 ","pages":"27-30"},"PeriodicalIF":2.0,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11809357/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143391620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transurethral Water Vapor Ablation: Potential for a Novel Prostate Cancer Management Strategy.
IF 2
Research and Reports in Urology Pub Date : 2025-02-03 eCollection Date: 2025-01-01 DOI: 10.2147/RRU.S498872
Christopher A Warlick, Benjamin D Spilseth, Christopher M Dixon
{"title":"Transurethral Water Vapor Ablation: Potential for a Novel Prostate Cancer Management Strategy.","authors":"Christopher A Warlick, Benjamin D Spilseth, Christopher M Dixon","doi":"10.2147/RRU.S498872","DOIUrl":"10.2147/RRU.S498872","url":null,"abstract":"<p><strong>Purpose: </strong>Targeted and precise application of thermal energy stored in sterile water vapor is a novel approach to treat cancerous prostate tissue. We report safety and oncological results of transurethral hemigland vapor ablation in a prospective, single-arm study in men with unilateral, intermediate-risk localized prostate cancer.</p><p><strong>Patients and methods: </strong>Men with biopsy confirmed Gleason Grade Group 2 (GG2) adenocarcinoma of the prostate, mean age 64.6 years, PSA 5.2 ng/mL, and prostate volume 46.8 cc on TRUS were enrolled. Using cystoscopy and transrectal ultrasound (TRUS) guidance, water vapor (~103°C) was delivered to prostate zones for hemigland ablation inclusive of cancers identified by multiparamertric MRI (mpMRI) and biopsy. At 6-months, combined 12-core systematic and mpMRI fusion biopsy was performed. Subjects with no remaining GG2 disease were followed for 12 months. Those with residual or newly identified GG2 disease were eligible for a second vapor ablation and subsequent 6-month mpMRI fusion biopsy and were followed for at least 18 months after index treatment.</p><p><strong>Results: </strong>Fifteen subjects were successfully treated. At 6 months 4/15 subjects were identified for further management, two with residual GG2 cancer on the treated side, and two with newly identified GG2 cancer on the untreated contralateral side; one of two subjects with residual GG2 was ineligible for retreatment (unrelated myocardial infarction). Follow up at 12 to 18 months after initial or retreatment provided a final ≥GG2 negative biopsy in 14/15 (93.3%) subjects. Device or procedure-related adverse events (AEs) were mild/moderate and transient; none were serious AEs.</p><p><strong>Conclusion: </strong>Water vapor ablation has low morbidity. It is possible to successfully retreat residual disease or new lesions identified on surveillance with only transient mild to moderate adverse events and acceptable oncologic outcomes offering a new management strategy for localized prostate cancer.</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"17 ","pages":"17-25"},"PeriodicalIF":2.0,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11804875/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mature Teratoma Combined with Bladder Stones: A Case Report and Literature Review.
IF 2
Research and Reports in Urology Pub Date : 2025-01-30 eCollection Date: 2025-01-01 DOI: 10.2147/RRU.S497270
Anan Li, Xiaobo Wang, Chang Wang, Qingling Song, Yanbin Niu, Peng Wang, Juntao Yue
{"title":"Mature Teratoma Combined with Bladder Stones: A Case Report and Literature Review.","authors":"Anan Li, Xiaobo Wang, Chang Wang, Qingling Song, Yanbin Niu, Peng Wang, Juntao Yue","doi":"10.2147/RRU.S497270","DOIUrl":"10.2147/RRU.S497270","url":null,"abstract":"<p><p>Teratoma is neoplasia originating from a germ cell, which usually contains identifiable tissue derived from all three germ cell layers. The presence of teratoma is due to an organ being affected by a tumor, which generally occurs in ovary. Teratoma is also seen occasionally in some extragonadal organs. However, a primary teratoma in the bladder is a rare entity. We hereby present a case of bladder teratoma. A 53-year-old woman whose chief complaints were urinary interruption, pilimiction, and a stone in her urine was diagnosed by cystoscopy and received rehabilitation after tumor resection surgery. She was then symptom-free and further follow-up observation was in progress. We also include a literature review concerning primary bladder teratoma.</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"17 ","pages":"11-15"},"PeriodicalIF":2.0,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11789519/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143123485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Immunohistochemistry for AMACR/p504s and p63 in Distinguishing Prostate Cancer from Benign Prostate Tissue Samples in Botswana. 在博茨瓦纳,AMACR/p504s 和 p63 的免疫组化在区分前列腺癌和良性前列腺组织样本中的作用。
IF 2
Research and Reports in Urology Pub Date : 2025-01-22 eCollection Date: 2025-01-01 DOI: 10.2147/RRU.S492935
Pleasure Ramatlho, Moses Muganyizi Rugemalila, Leabaneng Tawe, Debanjan Pain, Ontlametse T Choga, Andrew Khulekani Ndlovu, Moses O Koobotse, Priti Lal, Timothy R Rebbeck, Giacomo M Paganotti, Mohan Narasimhamurthy, Lynnette Tumwine Kyokunda
{"title":"The Role of Immunohistochemistry for AMACR/p504s and p63 in Distinguishing Prostate Cancer from Benign Prostate Tissue Samples in Botswana.","authors":"Pleasure Ramatlho, Moses Muganyizi Rugemalila, Leabaneng Tawe, Debanjan Pain, Ontlametse T Choga, Andrew Khulekani Ndlovu, Moses O Koobotse, Priti Lal, Timothy R Rebbeck, Giacomo M Paganotti, Mohan Narasimhamurthy, Lynnette Tumwine Kyokunda","doi":"10.2147/RRU.S492935","DOIUrl":"10.2147/RRU.S492935","url":null,"abstract":"<p><strong>Introduction: </strong>Prostate cancer (CaP) is the most common malignancy and the second leading cause of cancer-related deaths among men in Botswana. Currently, diagnosing CaP relies on examining prostate biopsy samples, which can be challenging due to benign mimics. This study aims to evaluate the potential of Alpha-methyl acyl-CoA racemase (AMACR/p504s) and p63, as diagnostic markers for CaP. This may potentially validate the use of immunohistochemistry for detecting CaP in Botswana, where it is not routinely utilized.</p><p><strong>Methods: </strong>The study included 69 samples, comprising 5 prostatic chip specimens, 50 core biopsies, and 14 radical prostatectomy specimens. These cases were reviewed and categorized into CaP (49 cases) and benign prostatic hyperplasia (BPH) (20 cases). Immunohistochemistry was performed using AMACR/p504s and p63 immunohistochemical stains.</p><p><strong>Results: </strong>The study found that AMACR/p504s had a sensitivity of 96% and a specificity of 95%, while p63 had a sensitivity and specificity of 100%. PSA levels showed significant positive correlation with AMACR/p504s expression (<i>P</i> < 0.00001).</p><p><strong>Discussion: </strong>In this study, we have demonstrated the diagnostic utility of AMACR/p504s and p63 due to their high sensitivity and specificity in detecting CaP in Botswana, where these biomarkers are not yet widely used. Furthermore, utilizing these markers in conjunction with other diagnostic tools, such as PSA levels and morphological evaluation, could improve the diagnostic accuracy, especially in challenging cases where histopathological examination alone may be inconclusive.</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"17 ","pages":"1-10"},"PeriodicalIF":2.0,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11766141/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143053380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knowledge of Male Infertility and Acceptance of Medical Assistance Reproductive Technology Among Fertile and Infertile Senegalese Men. 塞内加尔男性对男性不育症的了解和对医疗辅助生殖技术的接受。
IF 2
Research and Reports in Urology Pub Date : 2024-12-24 eCollection Date: 2024-01-01 DOI: 10.2147/RRU.S487854
Oumar Gaye, Khadidiatou Ba, Mouhamed Diallo, Awa Niasse, Amdy Laye Counta, Modou Ndiaye, Moustapha Gning, Ablaye Gueye, Papa Ahmed Fall
{"title":"Knowledge of Male Infertility and Acceptance of Medical Assistance Reproductive Technology Among Fertile and Infertile Senegalese Men.","authors":"Oumar Gaye, Khadidiatou Ba, Mouhamed Diallo, Awa Niasse, Amdy Laye Counta, Modou Ndiaye, Moustapha Gning, Ablaye Gueye, Papa Ahmed Fall","doi":"10.2147/RRU.S487854","DOIUrl":"10.2147/RRU.S487854","url":null,"abstract":"<p><strong>Purpose: </strong>The objective of our study was to examine the knowledge of male infertility and the acceptance of assisted reproductive technology (ART) methods.</p><p><strong>Patients and methods: </strong>We conducted a descriptive, comparative, cross-sectional study from April 2023 to August 2023 in a center in Dakar. Included in the study were male patients aged 18 and older followed for male infertility (group 1) and fertile patients of the same age as those in group 1 (group 2). We designed a questionnaire assessing the sociodemographic characteristics of the respondents, their knowledge of male infertility, knowledge of ART, its acceptability, and the source of information about male infertility.</p><p><strong>Results: </strong>Our sample size consisted of 119 respondents for each group. The average age of respondents in both groups was 41.24 ± 8.42 years. Fifty-eight percent of respondents in group 1 were referred by their wife's gynecologist. Fifty-four percent of respondents in group 1 had a good knowledge of male infertility, and 42.86% had average knowledge of male infertility. The majority of respondents in group 1 (42.9%) and group 2 (40.3%) did not know the duration that defines infertility. Fifty-seven percent of respondents in Group 1 and 81.5% of respondents in Group 2 did not know what assisted reproductive technology meant. Eighty-six percent of respondents in Group 1 agreed to use ART for procreation. The majority of respondents in Group 1 (54.6%) and Group 2 (58.8%) attributed a success rate of between 35% and 75% to ART.</p><p><strong>Conclusion: </strong>Infertile men had better knowledge of male fertility than fertile men. Respondents in both groups, as well as the advanced age of men did not know the duration defining infertility. Poor knowledge of ART was also observed among respondents in both groups, and a better acceptance of ART methods was noted among infertile men.</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"16 ","pages":"343-355"},"PeriodicalIF":2.0,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11681773/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142903134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transperineal Drainage of Seminal Vesicle Abscess Under Local Anaesthetic: A Case Report. 局部麻醉下精囊脓肿经会阴引流1例。
IF 2
Research and Reports in Urology Pub Date : 2024-12-03 eCollection Date: 2024-01-01 DOI: 10.2147/RRU.S499990
Ali Hooshyari, Flavio Vasconcelos Ordones, Lodewikus Petrus Vermeulen
{"title":"Transperineal Drainage of Seminal Vesicle Abscess Under Local Anaesthetic: A Case Report.","authors":"Ali Hooshyari, Flavio Vasconcelos Ordones, Lodewikus Petrus Vermeulen","doi":"10.2147/RRU.S499990","DOIUrl":"10.2147/RRU.S499990","url":null,"abstract":"<p><p>A 44-year-old healthy Caucasian gentleman presented with fevers and right lower quadrant pain. He had mildly elevated inflammatory markers and computed tomography demonstrated cystic enlargement of the right seminal vesicle concerning for seminal vesicle abscess (SVA). SVA is a rare diagnosis and generally requires drainage for adequate source control. The patient was commenced on intravenous antibiotics and underwent uncomplicated transperineal drainage of seminal vesicle abscess under local anaesthetic. Urine culture confirmed infection with <i>Citrobacter koseri</i> and the patient was discharged on the first post-operative day with a 14-day course of oral co-trimoxazole. Six-week follow-up with multiparametric magnetic resonance imaging of the prostate shows no evidence of any prostatic lesions, prostatitis or recurrence of abscess.</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"16 ","pages":"337-341"},"PeriodicalIF":2.0,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11624677/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142802089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Importance of Diagnostics in the Treatment of Urinary Tract Infections in the United Kingdom. 诊断在治疗尿路感染在英国的重要性。
IF 2
Research and Reports in Urology Pub Date : 2024-11-27 eCollection Date: 2024-01-01 DOI: 10.2147/RRU.S483147
Allister Irvine, Joanne Watt, Mary Jo Kurth, John V Lamont, Peter Fitzgerald, Mark W Ruddock
{"title":"The Importance of Diagnostics in the Treatment of Urinary Tract Infections in the United Kingdom.","authors":"Allister Irvine, Joanne Watt, Mary Jo Kurth, John V Lamont, Peter Fitzgerald, Mark W Ruddock","doi":"10.2147/RRU.S483147","DOIUrl":"https://doi.org/10.2147/RRU.S483147","url":null,"abstract":"<p><p>Current diagnosis of urinary tract infections (UTIs) in the UK initially relies on self-reported patient symptoms with no point-of-care test robust enough to accurately identify the causative pathogen and inform on antibiotic susceptibility. In serious UTI cases, standard urine culture is regarded as the gold standard for diagnosis and involves direct isolation, culture and antibiotic susceptibility testing of pathogens. These methods are not suitable in initial UTI diagnosis and treatment because of the time taken to conduct these analyses (≥3 days). Inaccurate and slow diagnostics can lead to unnecessary or incorrect antibiotic prescribing, which can lead to increased antimicrobial resistance and poorer patient outcomes. Novel point-of-care testing devices are urgently needed to improve the diagnostics of UTIs. In this article, we highlight novel point-of-care tests which are in development that can detect UTI-causing pathogens rapidly and accurately. These devices require additional studies to prove their clinical utilities. Adoption of these technologies can empower general practitioners (GPs) and pharmacists in prescribing decisions and improve antimicrobial stewardship.</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"16 ","pages":"327-335"},"PeriodicalIF":2.0,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11608548/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142771925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信